Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-10-25

FDA Approved: TECVAYLI — Original Application (Janssen Biotech, Inc.)

View source ↗

Summary

FDA approved TECVAYLI (teclistamab-cqyv) from Janssen Biotech, Inc. as an original application for the treatment of multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TECVAYLI (TECLISTAMAB-CQYV)

Snippet

ORIG AP for TECVAYLI (TECLISTAMAB-CQYV)